Cargando…

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis

AIM: To review and compare the PON-1 arylesterase activity between coronary artery disease (CAD) and non-CAD patients. METHODS: Data were obtained by searching MEDLINE and Scopus for all investigations published between January 1, 2000 and March 1, 2021 comparing PON-1 arylesterase activity between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuin, Marco, Trentini, Alessandro, Marsillach, Judit, D'Amuri, Andrea, Bosi, Cristina, Roncon, Loris, Passaro, Angelina, Zuliani, Giovanni, Mackness, Mike, Cervellati, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930235/ https://www.ncbi.nlm.nih.gov/pubmed/35308142 http://dx.doi.org/10.1155/2022/4264314

Ejemplares similares

Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
por: Rosta, Valentina, et al.
Publicado: (2020)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Risk of dementia in patients with atrial fibrillation: Short versus long follow‐up. A systematic review and meta‐analysis
por: Zuin, Marco, et al.
Publicado: (2021)

Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)

Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases
por: Marsillach, Judit, et al.
Publicado: (2021)

Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis
por: Bassu, Stefania, et al.
Publicado: (2022)

Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1
por: Trentini, Alessandro, et al.
Publicado: (2019)

Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
por: Passaro, Angelina, et al.
Publicado: (2018)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2022)

Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
por: Marsillach, Judit, et al.
Publicado: (2009)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2021)

Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study
por: Mackness, Bharti, et al.
Publicado: (2012)

Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet
por: de la Iglesia, Rocio, et al.
Publicado: (2014)

Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer’s Disease
por: Salazar, Jose Gregorio, et al.
Publicado: (2021)

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
por: Schilcher, Irene, et al.
Publicado: (2021)

Arylesterase activity of paraoxonase 1 (PON1) on HDL(3) and HDL(2): Relationship with Q192R, C-108T, and L55M polymorphisms
por: Valencia C, Sandra Y., et al.
Publicado: (2021)

Prognostic Role of Metabolic Syndrome in COVID-19 Patients: A Systematic Review Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2021)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
por: Gabaldó, Xavier, et al.
Publicado: (2022)

Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
por: Erdem, Fazile Hatipoglu, et al.
Publicado: (2010)

Paraoxonase and Arylesterase Activities in Dipper and Non-Dipper Prehypertensive Subjects
por: Yuksel, Murat, et al.
Publicado: (2015)

Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
por: Asare, George Awuku, et al.
Publicado: (2018)

Alzheimer’s Disease and Paraoxonase 1 (PON1) Gene Polymorphisms
por: Saeidi, Mohsen, et al.
Publicado: (2017)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
por: Idrees, Muhammad, et al.
Publicado: (2018)

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
por: Elkiran, Emin T, et al.
Publicado: (2007)

Serum Paraoxonase/Arylesterase Activity and Oxidative Stress Status in Children with Metabolic Syndrome
por: Eren, Erdal, et al.
Publicado: (2014)

Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease
por: Reichert, Cadiele Oliana, et al.
Publicado: (2019)

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis
por: Riedmaier, Stephan, et al.
Publicado: (2011)

Misconceptions about paraoxonase-1
por: Mackness, Michael, et al.
Publicado: (2021)

Erratum: Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
Publicado: (2019)

Paraoxonase and Arylesterase Activities, Lipid Profile, and Oxidative Damage in Experimental Ischemic Colitis Model
por: Unal, Ethem, et al.
Publicado: (2012)

The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats
por: Takaeidi, Mohammad Reza, et al.
Publicado: (2014)

Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
por: Ayan, Durmuş, et al.
Publicado: (2019)

Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and Inflammation
por: Tisato, Veronica, et al.
Publicado: (2019)

Effect of Exercise Repetitions on Arylesterase Activity of PON1 in Plasma of Average-Trained Men—The Dissociation between Activity and Concentration
por: Otocka-Kmiecik, Aneta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_79e3td7aava1cdcivc9brgjejd